Voyageur Pharmaceuticals Ltd.VM.V

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd. is a Calgary-based pharmaceutical company focused on the development and production of barium and iodine Active Pharmaceutical Ingredients (APIs) for medical imaging contrast agents. The company holds Health Canada licenses for five barium contrast products and has a collaboration with Bayer for iodine contrast media research and development, with plans to establish integrated manufacturing facilities in the United States.

Key ratios

FCF / Sales

-7364.2%TTM

2025 -27032.5%

ROA

-57.5%TTM

2025 -63.4%2024 -39.8%2023 -35.9%

ROE

-361.9%TTM

2025 -415.0%2024 -181.1%2023 -96.5%

Recent news

Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker 2026-07-17 · Newsfile Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility 2026-06-23 · TheNewsWire Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underway 2026-06-18 · TheNewsWire Voyageur Announces Shares for Debt Settlement and Stock Option Repricing 2026-04-17 · InvestorNews

Track VM.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer